Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 1997

View Archived Issues

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

ET antagonists disclosed by Merck KGaA

Microcide reveals new cephalosporins active against resistant organisms

Opioid antagonists/agonists described by Toray

Banyu discovers potent new antitumor agent

Natural antitumor compounds described by Banyu

Inhibitors of 5alpha-reductase from Kyowa Hakko

Antiviral pyrimidine nucleosides described by Yamasa

Prodrugs of nitrogen mustard with selective antitumor activity

MP-52 to be developed worldwide by HMR

NDA to be submitted in Japan for nevirapine

Glaxo to submit NDA in Japan for lamivudine in hepatitis

Tamsulosin cleared by FDA

Protease inhibitors in Japan

PharmaSciences and BTG extend license for hydrogel drug delivery technology

Fujisawa and Solvay sign marketing agreement for antidepressant

IDEC Pharmaceuticals: Q1 1997 highlights

Novel antiinflammatory agent from Parke-Davis

Sano: Q1 1997 highlights

Neutralase effective for heparin reversal in CAB

GalaGen: Q1 1997 highlights

OXiGENE: Q1 1997 highlights

Algos: Q1 1997 highlights

BY-963 for delineation of myocardial perfusion during cardiac surgery

Clevidipine for controlling hypertension after CABG

Favorable hemodynamic profile of aptiganel during general anesthesia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...